Label: Information for the User
Viaflo Glucose 10%Perfusion Solution
Active Ingredient: Glucose
Read this label carefully before starting to use this medication, because it contains important information for you.
This medication is called “Viaflo Glucose 10%Perfusion Solution”, but it will be referred to as “Viaflo Glucose 10%” in the rest of this label.
1.What is Viaflo Glucose 10% and what it is used for
2.What you need to know before Viaflo Glucose 10% is administered
3.How Viaflo Glucose 10% will be administered
4.Possible adverse effects
5.Storage of Viaflo Glucose 10%
6.Contents of the package and additional information
Viaflo Glucosa 10% is a sugar (glucose) solution in water. Glucose is one of the body's main sources of energy. This perfusion solution provides 400 kilocalories per liter.
Viaflo Glucosa 10% is used for:
diluting with water other medications that are desired to be administered intravenously.
Do not administer Viaflo Glucosa 10% if you suffer from any of the following conditions:
If another medication is added to your infusion solution, read the package insert. This will ensure that you can take that medication.
Viaflo Glucosa 10% is a hypertonic (concentrated) solution. Your doctor will take this into account when calculating the amount of solution to be administered.
If you develop or have developed any of the following conditions, inform your doctor.
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, convulsions, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
When you receive this infusion,your doctor will monitor:
Your doctor will adjust the amount of infusion solution to be administered based on the results of the tests. These tests will indicate to your doctor if you need additional potassium, a blood chemical. If necessary, it can be administered intravenously.
As Viaflo Glucosa 10% contains sugar (glucose), and may cause high blood sugar levels (hyperglycemia).if this occurs, your doctor may:
This is very important:
This solution will not be administered using the same needle as a blood transfusion, as the red blood cells may be damaged or cause clumping.
Children
Viaflo Glucosa 10%should be administered with special care in children.
Children should receive Viaflo Glucosa 10% from a doctor or nurse. The amount administered should be determined by a pediatric specialist and will depend on the child's age, weight, and condition. If it is used to administer or dilute another medication, or if other medications are administered at the same time, the dose may also be affected.
When the infusion is administered to children, your doctor will take blood and urine samples to monitor the amount of electrolytes such as potassium in the blood (plasma electrolytes).
Newborns - especially premature and low-birth-weight babies - are at higher risk of developing low or high blood sugar levels (hypoglycemia or hyperglycemia). Therefore, they require close monitoring during treatment with glucose solutions by intravenous infusion, which ensures an adequate control of blood sugar levels to prevent potential long-term adverse effects. Low blood sugar levels in newborns can cause prolonged convulsions, coma, and brain damage. High blood sugar levels can cause cerebral hemorrhage, bacterial or fungal infections, eye damage (retinopathy of prematurity), intestinal infections (necrotizing enterocolitis), respiratory problems (bronchopulmonary dysplasia), prolonged hospital stay, and death.
When administered to a newborn,,the solution bag may be connected to a pump infusion device, whichallows for the exact administration of the required amount over the defined time interval. Your doctor or nurse will be controlling the device to ensure safe administration.
Children (including newborns and older children) receivingViaflo Glucosa10% are at higher risk of having low sodium levels in the blood (hypotonic hyponatremia) and a disorder affecting the brain due to low plasma sodium levels (hypontremic encephalopathy).
Other medications andViaflo Glucosa 10%
Inform your doctor or pharmacist if you are using, have used recentlyor may need to useany other medication.
Viaflo Glucosa 10% and any other medication taken at the same time may affect each other.
Do not use Viaflo Glucosa 10% with certain hormones (catecholamines) including adrenaline or steroids, as they increase blood sugar levels.
Some medications act on the vasopressin hormone. These may include:
Use of Viaflo Glucosa 10% with food and drinks
You should ask your doctor what you can eat or drink.
Pregnancy, breastfeedingand fertility
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before using this medication.
Pregnancy
Viaflo glucosa 10% can be used during pregnancy. However, caution should be exercised when using a glucose solution during labor.
Fertility
There is insufficient data on the effect of glucose on fertility, although no effect is expected.
Breastfeeding
There is insufficient data on the use of a glucose solution during breastfeeding, although no effect is expected. Viaflo glucosa 10% can be used during breastfeeding.
However, if another medication is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and operating machinery
Consult your doctor or nurse before driving or operating machinery.
Glucose 10% Viaflo will be administered by a doctor or nurse. Your doctor will decide how much you need and when to administer it. This will depend on your age, weight, physical condition, and the reason for treatment. The amount you receive may also be influenced by other treatments you are receiving.
You should not receive Glucose 10% Viaflo if there are particles floating in the solution or if the container is damaged in any way.
Glucose 10% Viaflo is usually administered through a plastic tube connected to a needle inserted into a vein. A vein in the arm is often used to administer the infusion. However, your doctor may administer the medication in another way.
Your doctor will monitor the following before and during the infusion:
- the amount of fluid in your body
- the acidity of your blood and urine
- the amount of electrolytes in your body (particularly sodium, in patients with high levels of the vasopressin hormone, or those taking other medications that increase the effect of vasopressin).
Any unused solution should be discarded. You should not receiveGlucose 10% Viaflofrom a started bag.
If you receive more Glucose 10% Viaflo than you should
If you receive an excessive amount of Glucose 10% Viaflo (overdose) or if it is administered too quickly or too frequently, the following symptoms may occur:
!
If you develop any of these symptoms, inform your doctor immediately. Your infusion will be stopped or the infusion rate will be reduced. Insulin will be administered, and you will receive treatment based on your symptoms.
If a medication has been added to Glucose 10% Viaflo before the excessive administration, that medication may also cause symptoms. Please read the list of possible symptoms in the prospectus of the added medication.
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone 915.620.420
If you interrupt the infusion withGlucose 10% Viaflo
Your doctor will decide when to stop this infusion.
If you have any other questions about the use of this product, ask your doctor or nurse.
Like all medications,this medicationcan cause side effects, although not everyone will experience them.
Side effects may include:
If a medication has been added to the perfusion solution, it may also cause side effects. These side effects will depend on the added medication. You should read the list of possible symptoms in the prospectus of the added medication.
If any side effect occurs, the perfusion should be stopped.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Viaflo Glucose 10% SHOULD NOT BE ADMINISTERED AFTER THE EXPIRATION DATE THAT APPEARS ON THE BAGAND ON THE BOX AFTERcad. The expiration date is the last day of the month indicated.
Do not administer Viaflo Glucose 10% if there are floating particles in the solution or if the unit is damaged in any way.
Composition ofViaflo Glucose 10%
The active ingredient is glucose (as monohydrate): 100 g per liter.
The only other component is water for injection.
Formula for 250 ml
Glucose (as monohydrate): 25 g
Formula for 500 ml
Glucose (as monohydrate): 50 g
Formula for 1000 ml
Glucose (as monohydrate): 100 g
Appearance of Viaflo Glucose 10% and packaging contents
Viaflo Glucose 10% is a transparent solution, without visible particles. It is supplied in polyolefin/polyamide plastic bags (Viaflo). Each bag is wrapped in a sealed plastic protective overbag..
The bag sizes are:
Carton packaging contents:
Only some sizes of packaging may be marketed.
Marketing authorization holder and manufacturers
Marketing authorization holder:
Baxter, S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia)
Spain
Manufacturer:
Bieffe Medital S.A.
Ctra de Biescas, Senegüé
22666 Sabiñánigo (Huesca)
Spain
Last review date of this leaflet:April 2018
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
This information is intended solely for healthcare professionals:
Handling and preparation
The infusion solution must be visually checked before use.
Parenteral solutions must be visually inspected before administration to detect particles and discoloration, whenever the solution and packaging permit.Use the bag only if the solution is transparent, contains no visible particles, and the packaging is not damaged. It must be administered immediately after the infusion set is inserted.
Do not remove the bag from its overbag until it is ready for use.
The inner bag maintains the sterility of the product.
Do not connect plastic containers in series. This type of use may cause gas embolism due to residual air carried from the primary container before the administration of the liquid contained in the secondary container is completed.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates may cause gas embolism if the residual air in the container is not completely evacuated before administration.The use of an intravenous administration set with a ventilation filter in the open position may cause a gas embolism. This type of intravenous administration set with the ventilation filter in the open positionshould not be used with flexible plastic containers.
The solution must be administered with a sterile equipment using an aseptic technique. The equipment must be primed with the solution to prevent air entry into the system.
The addition of electrolytes may be indicated based on the clinical needs of the patient.
Medicaments may be added before administration or during administration through the resellable medication addition port. When used, the final osmolarity must be checked before parenteral administration. The mixture must be aseptic and must be prepared carefully and meticulously. Solutions containing added medicaments must not be stored and must be used immediately.
To avoid a potentially fatal overdose during the infusion of intravenous solutions in newborns, special attention must be paid to the administration method. When using a syringe pump to administer liquids or medicaments intravenously to newborns, do not leave a liquid bag connected to the syringe.
When using a perfusion pump, all clamps of the intravenous administration equipment must be closed before removing the administration set from the pump, or changing it. This is required regardless of whether the administration equipment has an anti-free flow device.
The complete device and its administration by intravenous perfusion must be frequently monitored.
Dispose of after single use.
Dispose of unused remnants.
Do not reconnect partially used bags.
Do not store solutions containing other medicaments.
Aseptic technique must be used when adding medicaments to Viaflo Glucose 10%.
Mix the solution well when adding medicaments.
1.Opening
a.Remove the Viaflo container from the protective overbag immediately before use.
b.Check for small leaks by pressing the inner bag firmly. If leaks are detected, discard the solution, as it may not be sterile.
c.Check the transparency of the solution and the absence of foreign particles. Discard the solution if it is not transparent or contains foreign particles.
2.Preparation for administration
Use sterile material for preparation and administration.
a.Hang the container by the hanger.
b.Remove the plastic protector from the outlet port at the bottom of the container:
-grasp the small protrusion on the neck of the port with one hand,
-grasp the long protrusion on the cap with the other hand and turn,
-the cap will come loose.
c.Use an antisepsis method to prepare the infusion.
d.Connect the administration equipment. Consult the instructions accompanying the equipment for its connection, priming, and administration of the solution.
3.Techniques for injecting added medicaments
Warning: Added medicaments may be incompatible.
To add medication before administration
a.Disinfect the medication addition port.
b.Using a syringe with a 19 (1.10 mm) to 22 (0.70 mm) gauge needle, puncture the resellable medication addition port and inject.
c.Mix the medication and solution carefully. For high-density medicaments, such as potassium chloride, gently move the tubes while in the vertical position and mix.
d.Warning: Do not store bags with added medication.
To add medication during administration
a.Close the clamp of the equipment.
b.Disinfect the medication addition port.
c.Using a syringe with a 19 (1.10 mm) to 22 (0.70 mm) gauge needle, puncture the resellable medication addition port and inject.
d.Remove the container from the intravenous support and/or turn it to place it in the vertical position.
e.Tap both ports gently while the container is in the vertical position.
f.Mix the solution and medication carefully.
g.Place the container back in the administration position, reopen the clamp, and continue with administration.
4.Expiry in use (added medicaments)
The chemical and physical stability of the medicaments in the pH of Viaflo Glucose 10% in the Viaflo container must be determined before use.
From a microbiological point of view, the diluted product must be used immediately unless reconstitution has been carried out in controlled and validated aseptic conditions. If not used immediately, the conditions and storage times used are the responsibility of the user.
5.Medicament incompatibilities
The glucose solution must not be administered simultaneously with, before, or after blood administration through the same infusion set, as it may cause hemolysis and clot formation.
The incompatibility of the medicaments to be added with Viaflo Glucose 10% must be evaluated before adding them.
In the absence of incompatibility studies, this product must not be mixed with others.
The product label of the medicament to be added must be consulted.
Before adding a medicament, verify that it is soluble and stable in water within the pH range of Viaflo Glucose 10% (pH 3.5 to 6.5).
When adding a compatible medicament to Viaflo Glucose 10%, the solution must be administered immediately.
Medicaments that are not compatible must not be used.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.